The relationship between insulin resistance and hypercoagulability in acute ischemic stroke

European Neurology

Volumn 64, Issue 4, 2010, Pages 201-206

  Ozkul, Ayca ^a   Turgut, Eylem Telli ^a   Akyol, Ali ^a   Yenisey, Cigdem ^a   Kadikoylu, Gurhan ^a   Tataroglu, Cengiz ^a   Kiylioglu, Nefati ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Hypercoagulability; Insulin resistance; Natural anticoagulants; Stroke severity

Indexed keywords

FIBRINOGEN; PROTEIN C; PROTEIN S; VON WILLEBRAND FACTOR;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE;

AGED; FEMALE; FIBRINOGEN; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PROTEIN C; PROTEIN S; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; STROKE; THROMBOPHILIA; VON WILLEBRAND FACTOR;

EID: 77955651653     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319196     Document Type: Article

References (48)

1. Moller DE, Flier JS: Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938-948.
2. Robinson LE, van Soeren MH: Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004; 15:45-62.
3. Melamed E: Reactive hyperglycemia in patients with acute stroke. J Neurol Sci 1976; 29: 267-275.
4. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-2432.
5. Yudkin JS: Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care 1999;22(Suppl 3):C25-C30.
6. Kohler HP: Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Sw iss Med Wk ly 2002; 132: 241-252.
7. Mertens I, Gaal FV: Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002; 3: 85-101.
8. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW: Hy-perinsulinemia, hyperglycemia, and impaired hemostasis. JAMA 2000; 283:221-228.
9. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP: Clustering of procoagulation, inflammation and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000; 152:897-907.
10. Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrières J: Prevalence of insulin resistance syndrome in Southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 2003; 25:1371-1377.
11. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E, Bonadonna RC: Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105: 576-582.
12. Imperatore G, Riccardi G, Iovine C, Rivel-lese AA, Vaccaro O: Plasma fibrinogen: a new factor of the metabolic syndrome. A population based study. Diabetes Care 1998; 21: 649-654.
13. Haapaniemi E , Soinne L, Syrjälä M, Kaste M, Tatlisumak T: Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke. Acta Neurol Scand 2004; 110:242-247.
14. Anzola GP, Magoni M, Ascari E, Maffi V: Early prognostic factors in ischemic stroke. The role of protein C and protein S. Stroke 1993; 24:1496-1500.
15. Berge E, Friis P, Sandset PM: Hemostatic activation in acute ischemic stroke. Thromb Res 2001; 101:13-21.
16. Rewers M, Zaccaro D, D'Agostino R, Haffner S, Saad MF, Selby JV, Bergman R, Savage P; Insulin Resistance Atherosclerosis Study Investigators: Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27:781-787.
17. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE: Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. Circulation 2004; 109:706-713.
18. Orlov SV, Domashenko MA, Kostyreva MV, Shabalina AA, Ionova VG, Tanashian MM: Hemorheology and hemostasis in patients suffering from ischemic cerebral stroke and metabolic syndrome. Klin Med (Mosk) 2007; 85:40-44.
19. Landi G, D'Angelo A, Boccardi E, Candelise L , Mannucci PM, Nobile Orazio E, Morabito A: Hypercoagulability in acute stroke: prognostic significance. Neurolog y 1987; 37: 1667-1671.
20. Takano K, Yamaguchi T, Okada Y, Kagehiro U, Kisiel W, Kato H: Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. Thromb Res 1990; 58: 481-491.
21. Takano K, Yamaguchi T, Kato H, Omae T: Activation of coagulation in acute cardioem-bolic stroke. Stroke 1991; 22:12-16.
22. Takano K, Yamaguchi T, Uchida K: Markers of hypercoaguble state following acute isch-emic stroke. Stroke 1992; 23: 194-198.
23. Yamazaki M, Uchiyama S, Maruyama S: Alterations of haemostatic markers in various subtypes and phases of stroke. Blood Coagul Fibrinolysis 1993; 4:707-712.
24. Mayer SA, Sacco RL, Hurle-Jensen A, Shi T, Mohr JP: Free protein S deficiency in acute ischemic stroke. Stroke 1993; 24:224-227.
25. Akyol A, Ozkul A, Yenisey C, Kiylioglu N: The relationship between protein C, protein S and cytokines in acute ischemic stroke. Neuroimmunomodulation 2006; 13: 187-193.
26. Haapaniemi E, Tatlisumak T, Soinne L, Syrjälä M, Kaste M: Natural anticoagulants (antithrombin III, protein C, and protein S) in patients with mild to moderate ischemic stroke. Acta Neurol Scand 2002; 105:107-114.
27. Rallidis LS, Vikelis M, Panagiotakos DB, Liakos GK, Krania E, Kremastinos DT: Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients. Acta Neurol Scand 2008; 117:415-420.
28. Turaj W, Slowik A, Dziedzic T, Pulyk R, Adamski M, Strojny J, Szczudlik A: Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. J Neurol Sci 2006; 246: 13-19.
29. Di Napoli M, Papa F, Bocola V: Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 20 01; 32: 133-138.
30. Sherman DG, Atkinson RP, Chippendale T, Levin KA, Ng K, Futrell N, Hsu CY, Levy DE: Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Tria l. JA MA 2000; 283: 2395-2403.
31. Hennerici MG, Kay R, Bogousslavsky J, Len-zi GL, Verstraete M, Orgogozo JM; ESTAT investigators: Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial. Lancet 2006; 368:1871-1878.
32. Oláh L, Csépány T, Bereczky Z, Kerényi A, Misz M, Kappelmayer J, Csiba L: Activity of natural coagulation inhibitor proteins in the acute phase of ischaemic stroke. Ideggyogy Sz 2005; 58: 33-39.
33. Bernard TJ, Fenton LZ, Apkon SD, Boada R, Wilkening GN, Wilkinson CC, Soep JB, Miyamoto SD, Tripputi M, Armstrong-Wells J, Benke TA, Manco-Johnson MJ, Goldenberg NA: Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke. J Pediatr 2010; 156:651-656.
34. Vila N, Reverter JC, Yague J, Charmorro A: Interaction between IL-6 and the natural anticoagulant system in acute stroke. J Inter-feron Cytokine Res 2000; 20:325-329.
35. Sato M, Suzuki A, Nagata K , Uchiyama S : Increased von Willebrand factor in acute stroke patients with atrial fibrillation. J Stroke Cerebrovasc Dis 2006; 15:1-7.
36. Melamed E: Reactive hyperglycemia in patients with acute stroke. J Neurol Sci 1976; 29: 267-275.
37. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-2432.
38. Garg R, Chaudhuri A, Munschauer F, Dan-dona P: Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 2006; 37: 267-273.
39. Chmielewska B, Hasiec T, Belniak-Legie? E, Stelmasiak Z: Usefulness of current and retrospective markers of glycemia for early prognostication of ischemic stroke in diabetics and non-diabetics. Ann Univ Mariae Curie Sk lodowska Med 1999; 54: 261-267.
40. Murros K, Fogelholm R, Kettunen S, Vuorela AL, Valve J: Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction. J Neurol Sci 1992; 111: 59-64.
41. Christensen H, Boysen G: Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur J Neurol 2002; 9: 297-301.
42. Gray CS, Hildreth AJ, Alberti GK, O'Connell JE: Poststroke hyperglycemia: natural history and immediate management. Stroke 2004; 35: 122-126.
43. Allport L, Baird T, Butcher K, Macgregor L, Prosser J, Colman P, Davis S: Frequency and temporal profile of poststroke hyperglyce-mia using continuous glucose monitoring. Diabetes Care 2006; 29:1839-1844.
44. Agewall S, Bokemark L, Wikstrand J, Lindahl A, Fagerberg B: Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old men. Thromb Haemost 2000; 84: 571-575.
45. De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M , Laudadio E , Giorgino R : Lowe randrogenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism 1997; 46: 12 87-1293.
46. De Pergola G, De Mitrio V, Giorgino F, Sciaraffia M, Minenna A, Di Bari L, Pannacciulli N, Giorgino R: Increase in both prothrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. Int J Obes Relat Metab Disord 1997; 21: 527-535.
47. Agewall S: Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group. J Intern Med 1999; 246: 489-495.
48. Schneider DJ: Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coron Artery Dis 2005; 16:473-476.